Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation

Completed · Phase 2

Conditions studied: Graft vs Host Disease

In brief

Atorvastatin for prevention of acute GVHD

Key facts

Study ID

NCT01175148

Run by

West Virginia University

People needed

60

Starts

2010-07-01

Expected to finish

2014-12-01

Last updated by the study team

2017-06-07

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• West Virginia University Hospitals Mary Babb Randolph Cancer Center — Morgantown, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.